Research Calls
- Upgrades:
- BAE Systems (BAESY) upgraded to Buy from Neutral at UBS
- Banco de Sabadell (BNDSF) upgraded to Buy from Neutral at UBS
- FibroGen (FGEN) upgraded to Outperform from Mkt Perform at William Blair
- FleetCor (FLT) upgraded to Buy from Neutral at BofA Securities; tgt raised to $240
- Inter & Co (INTR) upgraded to Buy from Neutral at Goldman; tgt lowered to $4.20
- LyondellBasell (LYB) upgraded to Overweight from Neutral at Atlantic Equities; tgt $110
- New Fortress Energy (NFE) upgraded to Buy from Neutral at BTIG Research; tgt $50
- Societe Television Francaise 1 (TVFCF) upgraded to Equal Weight from Underweight at Barclays
- Williams Cos (WMB) upgraded to Overweight from Hold at US Capital Advisors; tgt $36
- WPP plc (WPP) upgraded to Overweight from Equal Weight at Barclays
- Downgrades:
- Airbus (EADSY) downgraded to Sell from Buy at UBS
- Bank of America (BAC) downgraded to Neutral from Overweight at Atlantic Equities; tgt $40
- Crestwood Equity Partners (CEQP) downgraded to Hold from Buy at US Capital Advisors; tgt $29
- DCP Midstream (DCP) downgraded to Hold from Buy at US Capital Advisors; tgt $42
- Eastern Bankshares (EBC) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $15
- Enerflex (EFXT) downgraded to Sector Perform from Outperform at National Bank Financial
- Finmeccanica SpA (FINMY) downgraded to Neutral from Buy at UBS
- HomeStreet (HMST) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $29
- Invitae (NVTA) downgraded to Sell from Neutral at Goldman; tgt $2
- iStar (STAR) downgraded to Mkt Perform from Outperform at Raymond James
- Legal & General Group (LGGNY) downgraded to Hold from Buy at Berenberg
- Nokia (NOK) downgraded to Neutral from Buy at UBS
- Nu Skin (NUS) downgraded to Hold from Buy at Jefferies; tgt lowered to $39
- Q2 Holdings (QTWO) downgraded to Neutral from Outperform at Robert W. Baird; tgt $32
- RELX (RELX) downgraded to Equal Weight from Overweight at Barclays
- Sierra Bancorp (BSRR) downgraded to Market Perform from Outperform at Hovde Group; tgt $24
- Thales (THLEF) downgraded to Neutral from Buy at UBS
- Truist (TFC) downgraded to Equal-Weight from Overweight at Stephens; tgt $53
- Ubisoft (UBSFY) downgraded to Underperform from Buy at Jefferies
- Others:
- AmerisourceBergen (ABC) resumed with an Outperform at Evercore ISI; tgt $185
- ARS Pharmaceuticals (SPRY) initiated with an Outperform at Wedbush; tgt $10
- Compass Therapeutics (CMPX) initiated with a Buy at Jefferies; tgt $8
- Incyte (INCY) initiated with an Overweight at Piper Sandler; tgt $100
- Kura Oncology (KURA) initiated with a Buy at Stifel; tgt $25
- Pacira BioSciences (PCRX) assumed with an Outperform at Wedbush; tgt lowered to $60
- Syndax Pharmaceuticals (SNDX) initiated with a Buy at Stifel; tgt $37